THANK YOU FOR SUBSCRIBING
Jun 27 - Jul 1, 2021, Virtual Event
Fueled by the ideas of thousands of attendees, the DIA 2021 Global Annual Meeting will bring together patients, industry, regulators, and academia from all points in the product lifecycle from 50+ countries. Our meeting is the intersection of science, healthcare, and regulation, with no boundaries—an intersection that provides the catalyst for thoughtful dialogue and debate. From 13 educational tracks, multiple ways to learn, continuing education opportunities, and a world-class exhibit hall, by joining us you’ll take on a key role in building the framework of the future—making connections, gaining skills and insights, and advancing science to improve global health.
Oct 19 - 21, 2021, New York City, NY
INTERPHEX is the premier pharmaceutical, biotechnology, and device development and manufacturing event to “Experience Science through Commercialization”. Based in New York, INTERPHEX brings over 10,000 global industry professionals and 625+ leading suppliers together to “Learn It, Experience It, Procure It” through a combination of no cost technical conference, exhibits, demonstrations and networking events to leverage quality, efficiency and cost effectiveness in today’s global market
Feb 24 - 25, 2021, Virtual Event, Virtual Event
Join us at PCT West Coast for a two-day journey into the insightful world of clinical trials. You’ll connect with an incredible gathering of experts and uncover practical advice from industry-leading researchers, peers and executives. Get ready for an event designed to deliver real value-packed insights, connections with fellow professionals and learn strategies you can put to use the very next day.
Feb 23 - 26, 2021, Virtual Event
Immuno-Oncology 360 Degree convened stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers. It will features presentations on the latest data affecting the science, clinical, and business advancements in Immuno-Oncology, partnership opportunities with all stakeholders in Immuno-Oncology, and access to KOLs driving the science.
Jan 27 - 29, 2021, Virtual Event
As the first microbiome-based therapeutic steps closer to approval, the scientific community continues to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker & diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by complex challenges. Part of the foremost conference series for microbiome researchers, the 5th Microbiome Movement – Drug Development Europe 2021 returns to unite leading scientists from the biopharmaceutical and academic community to pursue the causal role of the microbiome in disease, and help create a new generation of microbiome-targeted therapeutics with predictable modes of action and consistent clinical outcomes.
Jan 26 - 28, 2021, Virtual Event
The PARP & DDR Inhibitors Summit is your only industry-focused meeting dedicated to bringing DDR therapeutics to the clinic. The digital meeting will capitalize on the therapeutic application of PARP inhibitors by finding optimal treatment combinations and expanding its use in cancer indications, as well as exploring emerging targets such as Pol Theta. Join us and the VPs, Heads and Directors of Translational Oncology, Target Discovery, and Early Drug Development to discuss how to develop novel inhibitors of specific DNA repair enzymes that can be used as either monotherapy or in combination with other agents within predictable, identifiable, DDR-defective tumor populations.